Antithrombotic Treatment After Left Atrial Appendage Occlusion in Older Atrial Fibrillation Patients
Xiaojuan Liu, Sebastian Schneeweiss, Daniel Singer, Jerry Avorn, E Kevin Heist, Joshua Lin

TL;DR
This study examines how older patients with atrial fibrillation follow antithrombotic treatment after a procedure to prevent stroke, finding that adherence to the recommended protocol is low.
Contribution
The study provides real-world data on post-LAAO antithrombotic treatment adherence in a large cohort of older NVAF patients.
Findings
Only 23% of patients followed the standard post-LAAO treatment protocol.
Common deviations included no TEE at 45 days and early OAC discontinuation.
Older age and Black race were associated with prolonged OAC use.
Abstract
Left atrial appendage occlusion (LAAO) is an alternative to oral anticoagulants (OAC) for stroke prevention in nonvalvular atrial fibrillation (NVAF); however, real-world data on adherence to its postprocedural treatment protocol remain limited. We evaluated post-LAAO antithrombotic treatment patterns in a cohort of 16304 NVAF patients (mean [SD] age = 78 [6]; 47% female; CHA2DS2-VASc score = 5.0 [1.5]) undergoing first-time LAAO using Optum claims data 2015-2024. OAC discontinuation was defined as a ≥ 60-day gap in supply, and prolonged OAC use was operationally defined as either (1) an OAC refill following a TEE performed 30–90 days post-implantation or (2) OAC refill beyond 90 days post-implantation, regardless of TEE completion. Among LAAO recipients, 9844 (60%) received concomitant OAC and 3499 (10%) received P2Y12 inhibitor at implantation. Transesophageal echocardiography (TEE)…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAtrial Fibrillation Management and Outcomes · Cardiovascular Disease and Adiposity · Peripheral Artery Disease Management
